PRISM BioLab Co.,Ltd announced that it has raised ¥1,500 million in a round of funding on January 24, 2024. The transaction included participation from new investors Eli Lilly and Company and santec Holdings Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,030 JPY | +0.20% | +2.86% | +62.52% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
5,030 JPY | +0.20% | +2.86% | 379M | ||
760 USD | -1.50% | +3.41% | 684B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.52% | 379M | |
+12.94% | 109B | |
+0.91% | 30.23B | |
+12.31% | 22.34B | |
-11.83% | 18.66B | |
-8.62% | 16.99B | |
+15.54% | 16.24B | |
-5.91% | 12.07B | |
+1.93% | 10.99B | |
-15.91% | 8.36B |
- Stock Market
- Equities
- 6777 Stock
- News santec Holdings Corporation
- PRISM BioLab Co.,Ltd announced that it has received ¥1.5 billion in funding from santec Holdings Corporation, Eli Lilly and Company